Autres langues Bristol-Myers Squibb Company Lima

Actions

BMYUS

US1101221083

Produits pharmaceutiques

Cours en clôture Lima 24/09/2026			Varia. 5j.	Varia. 1 janv.
62,62 ^USD	0,00%		-2,31%	+16,26%

25/09	Bristol Myers Squibb annonce la première présentation des résultats de ZENBEXUS en association avec le daratumumab dans le cadre de l’étude de phase 3 EXCALIBER-RRMM menée chez des patients atteints d’un myélome multiple en rechute ou réfractaire	CI
25/09	Bristol Myers Squibb présente des résultats d'une étude de phase 3

Autres langues

25/09	Bristol Myers Squibb Announces First Presentation Of Results For ZENBEXUS In Combination With Daratumumab From Phase 3 EXCALIBER-RRMM Trial In Relapsed Or Refractory Multiple Myeloma
25/09	Bristol-Myers Squibb Says Zenbexus Combination Doubles MRD-Negative Complete Response in Multiple Myeloma Trial
25/09	Bristol Myers Squibb Announces First Presentation of Results for ZENBEXUS™ (iberdomide) in Combination with Daratumumab from Phase 3 EXCALIBER-RRMM Trial in Relapsed or Refractory Multiple Myeloma
22/09	Onco360(R) is a participating specialty pharmacy in the ZENBEXUS (iberdomide) limited dispense network
21/09	Onco360 Oncology Pharmacy Is Selected As Participating Specialty Pharmacy In ZENBEXUS Limited Dispense Network By Bristol-Myers Squibb
21/09	Pharma sector doubles down on AI to slash costs, timelines
21/09	Two favorable EU opinions for AstraZeneca
18/09	Bristol Myers Squibb to Report Results for Third Quarter 2026 on October 29, 2026
18/09	Anthropic quietly sets up biology lab as it ramps AI drug program
18/09	US weighs allowing most pharma licensing deals with China, sources say
17/09	Bristol Myers Squibb Presents Sotyktu (Deucravacitinib) Data Showing Durable Efficacy And Consistent Safety In Adults With Psoriatic Arthritis Over Two Years
17/09	Bristol Myers Squibb Reports Sustained Sotyktu Responses in Psoriatic Arthritis Through 2 Years
17/09	Bristol Myers Squibb Presents Sotyktu (deucravacitinib) Data Showing Durable Efficacy, Consistent Safety in Adults with Psoriatic Arthritis Over Two Years
17/09	Drugmakers prepare for next phase of space pharmaceuticals as ISS retirement nears
16/09	Novo Nordisk to Collaborate With Anthropic to Help Accelerate Drug Discovery, Development
16/09	Analystenempfehlungen: BMW, Elmos Semiconductor, Schindler, Stellantis, Apple, Chipotle…
16/09	Pharma sector doubles down on AI to slash costs, timelines
16/09	Wall Street vor der Zinsabrechnung
16/09	Afternoon Meeting: La hora de la verdad de los tipos de interés
16/09	Wall Street's Rate Reckoning
16/09	Bristol-Myers Squibb Company Declares Quarterly Dividend, Payable on November 2, 2026
16/09	Bristol-Myers Squibb Keeps Quarterly Dividend at $0.63 a Share, Payable Nov. 2 to Shareholders of Record on Oct. 2
16/09	Bristol Myers Squibb Announces Dividend
16/09	Analyst recommendations: Stellantis, Apple, BofA, Chevron, Chipotle…
10/09	Bristol Myers Squibb Insider Sold Shares Worth $403,498, According to a Recent SEC Filing